Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people starting Mounjaro notice muscle soreness, joint discomfort or a general achy feeling, particularly in the first few weeks of treatment. These aches and pains on Mounjaro are real, reported in clinical trial data, and in most cases settle on their own. The key question is knowing which aches are part of adjustment and which deserve a call to your prescriber. Mounjaro is a prescription-only medicine, and any unexpected or persistent symptoms should always be discussed with the clinician overseeing your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The discomfort people describe falls into a few distinct patterns. Generalised muscle soreness (sometimes described as a flu-like achiness) is probably the most common. It tends to appear in the first day or two after an injection and fades before the next dose is due. Joint pain, particularly in the knees and lower back, is also reported, though it is harder to pin on the medication alone since many people starting a weight-management programme are also increasing their activity level.
Back pain comes up frequently enough that it sits in the broader picture of body aches on Mounjaro. Whether the drug directly causes it or whether reducing calorie intake changes how the body distributes muscle and fat around the spine is not fully established. What is established is that the Mounjaro SmPC (the medicine's official summary of product characteristics, published on the electronic Medicines Compendium) lists musculoskeletal pain among its recorded adverse effects. That tells you these reports have a clinical basis, not just anecdote.
Injection-site reactions (localised tenderness, redness or a lump at the site) are separate from generalised aches and pains and are very common. Rotating between the abdomen, thigh and upper arm helps. Keep your pen in the fridge door so it is easy to grab and check the injection site choice each week without it becoming a guessing game.
Mild, transient aches that arrive predictably after each injection and settle within a few days are generally considered part of the adjustment process. They are frustrating, but they do not usually require stopping treatment. The decision becomes more urgent when pain is severe, comes on suddenly, or does not fit that predictable pattern.
The signal to take most seriously is persistent, severe abdominal pain, especially pain that spreads towards the back, with or without vomiting. In January 2026 the MHRA issued a Drug Safety Update confirming that acute pancreatitis is a known, if infrequent, serious side effect of GLP-1 medicines including tirzepatide. If you experience that symptom, the right response is to seek medical help promptly, not to wait and see. You can read more about the mechanism and safety profile of tirzepatide on our dedicated page.
Chest discomfort is a separate category again. If any ache is in or near the chest, it deserves urgent assessment, more detail on that specific concern is covered in our guide to chest pains on Mounjaro. The point is not to cause alarm but to be clear that the threshold for calling for help should be low when pain is unexpected or intense.
People starting Mounjaro often already live with conditions like osteoarthritis or chronic lower-back pain, both of which qualify as weight-related comorbidities under the medicine's licence. That overlap makes it genuinely difficult to know whether a new ache is the drug, a flare of an existing condition, or the effect of exercising more as part of the programme. A prescriber who has your medical history can help untangle that.
What the evidence does suggest is that sustained weight loss typically reduces the load on weight-bearing joints over time. The specific question of muscle aches on Mounjaro is worth reading alongside this page if your discomfort feels more muscular than articular. The NHS's patient-facing information on tirzepatide confirms that pain in the back, limbs and joints is among the side effects recorded during clinical development, so your experience is clinically recognised even if the exact mechanism remains under study.
If you are taking any other medicines alongside Mounjaro, there may occasionally be interaction considerations worth raising with your prescriber. For example, our guide to Xanax and Mounjaro explains how co-medications are reviewed before treatment is approved.
For mild discomfort, standard measures often help: staying well hydrated, keeping movement gentle rather than stopping altogether, and using over-the-counter pain relief if appropriate for you (always check with a pharmacist or your prescriber before adding any medicine). Aches that reliably ease between doses but return briefly after each injection tend to be dose-adjustment effects and frequently improve as the body acclimatises.
If aches persist at a particular dose for more than two to three weeks without settling, or if a dose increase consistently brings more severe discomfort, that is the conversation to have before any further titration. Good prescribing means adjusting the plan to suit the individual, not pushing through pain that is not resolving.
Thinking about whether Mounjaro is the right treatment for you, or whether you have questions about eligibility? Our free consultation page explains how our prescribers review your history before any treatment starts. There is no obligation, and the assessment is clinically thorough. Information on the broader side-effect profile sits in our overview of Mounjaro for weight management, and the detailed aches and pains resource covers additional patterns in more depth. If you have a question that is not answered here, our team is reachable via the contact page seven days a week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.